Denver Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
1,865
+4
+0.2% +$468 0.07% 96
2026
Q1
$224K Buy
+1,861
New +$215K 0.08% 97
2024
Q4
Sell
-1,913
Closed -$217K 84
2024
Q3
$217K Buy
1,913
+11
+0.6% +$1.31K 0.1% 84
2024
Q2
$235K Buy
1,902
+10
+0.5% +$1.29K 0.12% 77
2024
Q1
$250K Buy
1,892
+11
+0.6% +$1.36K 0.13% 74
2023
Q4
$205K Buy
+1,881
New +$195K 0.12% 71
2023
Q3
Sell
-1,833
Closed -$212K 72
2023
Q2
$212K Buy
+1,833
New +$208K 0.15% 67
2023
Q1
Sell
-1,813
Closed -$201K 82
2022
Q4
$201K Buy
+1,813
New +$185K 0.15% 66

Other funds holding MRK

Denver Wealth Management's MRK Position: Q2 2026 in Review

Denver Wealth Management increased its Merck (MRK) stake by 0.21% in Q2 2026, buying an estimated $468 and bringing the position to 1,865 shares worth $240K. The position accounts for 0.07% of the portfolio, ranked #96.

Denver Wealth Management first reported a position in MRK in Q4 2022 and has held it in 8 quarters since. The position peaked at $250K in Q1 2024. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Denver Wealth Management held 1,865 shares of Merck worth $240K as of Q2 2026.
  • Denver Wealth Management bought 4 Merck shares in Q2 2026, an estimated $468.
  • Merck made up 0.07% of Denver Wealth Management's portfolio in Q2 2026, its #96 holding.
  • Denver Wealth Management first reported a position in Merck in Q4 2022 and has held it in 8 quarters since.
  • Denver Wealth Management's Merck position peaked at $250K in Q1 2024.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Denver Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.